Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML. This evidence concerns the gene PTTG1IP and chronic myelogenous leukemia, BCR-ABL1 positive.